NTES-S
09999
JD HEALTH
06618
ALI HEALTH
00241
4
JD-SW
09618
5
BABA-W
09988
HK Stock MarketDetailed Quotes
02181 MABPHARM-B
- 0.580
- -0.060-9.38%
Market Closed Mar 31 16:08 CST
2.39BMarket Cap-17.06P/E (TTM)
0.680High0.580Low500.00KVolume0.640Open0.640Pre Close304.14KTurnover0.01%Turnover RatioLossP/E (Static)4.12BShares0.94052wk High25.22P/B2.39BFloat Cap0.25052wk Low--Dividend TTM4.12BShs Float1.800Historical High--Dividend LFY15.63%Amplitude0.250Historical Low0.608Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
MABPHARM-B Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 196.27%258.23M | 146.44%108.48M | 55.87%87.16M | 52.60%44.02M | -32.53%55.92M | -64.49%28.85M | --82.88M | --81.25M | ---- | ---- |
| Operating income | 196.27%258.23M | 146.44%108.48M | 55.87%87.16M | 52.60%44.02M | -32.53%55.92M | -64.49%28.85M | 82.88M | 81.25M | ||
| Cost of sales | -225.71%-38.83M | -127.93%-14.13M | 22.45%-11.92M | 43.93%-6.2M | 8.36%-15.38M | 34.08%-11.05M | ---16.78M | ---16.77M | ---- | ---- |
| Operating expenses | -225.71%-38.83M | -127.93%-14.13M | 22.45%-11.92M | 43.93%-6.2M | 8.36%-15.38M | 34.08%-11.05M | -16.78M | -16.77M | ||
| Gross profit | 191.60%219.39M | 149.47%94.36M | 85.58%75.24M | 112.57%37.82M | -38.67%40.54M | -72.40%17.79M | 66.11M | 64.48M | ||
| Selling expenses | -209.79%-151.57M | -157.35%-69.6M | -73.41%-48.93M | -77.18%-27.05M | -199.41%-28.21M | ---15.26M | ---9.42M | ---- | ---- | ---- |
| Administrative expenses | -5.49%-110.41M | -28.62%-60.65M | -15.57%-104.66M | 1.42%-47.15M | 0.08%-90.56M | -9.32%-47.83M | -37.75%-90.63M | -42.33%-43.76M | -4.52%-65.8M | -10.25%-30.74M |
| Research and development expenses | 38.96%-75.21M | 5.43%-56.29M | 16.70%-123.21M | 23.67%-59.53M | 43.88%-147.91M | 52.29%-77.99M | -118.88%-263.57M | -168.72%-163.46M | 10.26%-120.42M | -3.62%-60.83M |
| Impairment and provision | -340.05%-1.88M | -18.31%-756K | -261.86%-427K | ---639K | ---118K | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -340.05%-1.88M | -18.31%-756K | -261.86%-427K | ---639K | ---118K | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 3.22%2.28M | -23.90%793K | -90.25%2.21M | -89.13%1.04M | 176.49%22.62M | 925.84%9.59M | 48.13%8.18M | -102.90%-1.16M | -81.49%5.52M | 1,564.10%40.01M |
| Operating profit | 41.24%-117.4M | 3.51%-92.15M | 1.89%-199.78M | 16.01%-95.5M | 29.62%-203.63M | 20.98%-113.71M | -60.13%-289.34M | -179.06%-143.89M | -8.00%-180.69M | 38.75%-51.56M |
| Financing cost | -10.17%-10.55M | -20.45%-5.42M | -33.25%-9.58M | -44.91%-4.5M | -199.13%-7.19M | -144.99%-3.1M | 39.04%-2.4M | 51.71%-1.27M | 48.77%-3.94M | 33.95%-2.62M |
| Earning before tax | 38.89%-127.95M | 2.43%-97.57M | 0.69%-209.36M | 14.39%-100M | 27.74%-210.82M | 19.53%-116.81M | -58.01%-291.74M | -167.88%-145.16M | 8.84%-184.63M | 53.16%-54.19M |
| After-tax profit from continuing operations | 38.89%-127.95M | 2.43%-97.57M | 0.69%-209.36M | 14.39%-100M | 27.74%-210.82M | 19.53%-116.81M | -58.01%-291.74M | -167.88%-145.16M | 8.84%-184.63M | 53.16%-54.19M |
| Earning after tax | 38.89%-127.95M | 2.43%-97.57M | 0.69%-209.36M | 14.39%-100M | 27.74%-210.82M | 19.53%-116.81M | -58.01%-291.74M | -167.88%-145.16M | 8.84%-184.63M | 53.16%-54.19M |
| Profit attributable to shareholders | 38.89%-127.95M | 2.43%-97.57M | 0.69%-209.36M | 14.39%-100M | 27.74%-210.82M | 19.53%-116.81M | -58.01%-291.74M | -167.88%-145.16M | 8.84%-184.63M | 53.16%-54.19M |
| Basic earnings per share | 40.00%-0.03 | 0.00%-0.02 | 0.00%-0.05 | 33.33%-0.02 | 28.57%-0.05 | 25.00%-0.03 | -75.00%-0.07 | -300.00%-0.04 | 20.00%-0.04 | 66.67%-0.01 |
| Diluted earnings per share | 40.00%-0.03 | 0.00%-0.02 | 0.00%-0.05 | 33.33%-0.02 | 28.57%-0.05 | 25.00%-0.03 | -75.00%-0.07 | -300.00%-0.04 | 20.00%-0.04 | 66.67%-0.01 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data.
Unlock Now